GAROFALO HEALTH CARE SPA (GHC.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:GHC - IT0005345233 - Common Stock
5.42 EUR
-0.08 (-1.45%)
Taking everything into account, GHC scores 4 out of 10 in our fundamental rating. GHC was compared to 30 industry peers in the Health Care Providers & Services industry. GHC has only an average score on both its financial health and profitability. GHC has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- GHC had positive earnings in the past year.
- GHC had a positive operating cash flow in the past year.
- Each year in the past 5 years GHC has been profitable.
- In the past 5 years GHC always reported a positive cash flow from operatings.
1.2 Ratios
- GHC's Return On Assets of 3.66% is fine compared to the rest of the industry. GHC outperforms 70.00% of its industry peers.
- The Return On Equity of GHC (9.57%) is comparable to the rest of the industry.
- The Return On Invested Capital of GHC (6.52%) is better than 66.67% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for GHC is below the industry average of 6.46%.
- The last Return On Invested Capital (6.52%) for GHC is above the 3 year average (4.41%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.66% | ||
| ROE | 9.57% | ||
| ROIC | 6.52% |
ROA(3y)2.83%
ROA(5y)2.81%
ROE(3y)7.12%
ROE(5y)6.88%
ROIC(3y)4.41%
ROIC(5y)3.91%
1.3 Margins
- GHC's Profit Margin of 4.62% is fine compared to the rest of the industry. GHC outperforms 80.00% of its industry peers.
- In the last couple of years the Profit Margin of GHC has declined.
- GHC's Operating Margin of 9.37% is amongst the best of the industry. GHC outperforms 83.33% of its industry peers.
- GHC's Operating Margin has declined in the last couple of years.
- With a decent Gross Margin value of 44.90%, GHC is doing good in the industry, outperforming 63.33% of the companies in the same industry.
- In the last couple of years the Gross Margin of GHC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.37% | ||
| PM (TTM) | 4.62% | ||
| GM | 44.9% |
OM growth 3Y-0.19%
OM growth 5Y-3.37%
PM growth 3Y-11.52%
PM growth 5Y-7.03%
GM growth 3Y0.36%
GM growth 5Y-1.06%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GHC is destroying value.
- Compared to 1 year ago, GHC has about the same amount of shares outstanding.
- Compared to 5 years ago, GHC has more shares outstanding
- The debt/assets ratio for GHC has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 1.97 indicates that GHC is not a great score, but indicates only limited risk for bankruptcy at the moment.
- GHC's Altman-Z score of 1.97 is in line compared to the rest of the industry. GHC outperforms 46.67% of its industry peers.
- GHC has a debt to FCF ratio of 70.49. This is a negative value and a sign of low solvency as GHC would need 70.49 years to pay back of all of its debts.
- With a Debt to FCF ratio value of 70.49, GHC is not doing good in the industry: 73.33% of the companies in the same industry are doing better.
- A Debt/Equity ratio of 0.67 indicates that GHC is somewhat dependend on debt financing.
- GHC has a Debt to Equity ratio of 0.67. This is in the better half of the industry: GHC outperforms 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 70.49 | ||
| Altman-Z | 1.97 |
ROIC/WACC0.99
WACC6.58%
2.3 Liquidity
- GHC has a Current Ratio of 1.16. This is a normal value and indicates that GHC is financially healthy and should not expect problems in meeting its short term obligations.
- With a decent Current ratio value of 1.16, GHC is doing good in the industry, outperforming 63.33% of the companies in the same industry.
- A Quick Ratio of 1.12 indicates that GHC should not have too much problems paying its short term obligations.
- The Quick ratio of GHC (1.12) is better than 73.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
- The earnings per share for GHC have decreased strongly by -12.11% in the last year.
- The Earnings Per Share has been growing by 8.81% on average over the past years. This is quite good.
- GHC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.44%.
- Measured over the past years, GHC shows a quite strong growth in Revenue. The Revenue has been growing by 18.92% on average per year.
EPS 1Y (TTM)-12.11%
EPS 3Y5.52%
EPS 5Y8.81%
EPS Q2Q%2.71%
Revenue 1Y (TTM)10.44%
Revenue growth 3Y18.48%
Revenue growth 5Y18.92%
Sales Q2Q%3.08%
3.2 Future
- The Earnings Per Share is expected to grow by 6.47% on average over the next years.
- GHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.51% yearly.
EPS Next Y3.45%
EPS Next 2Y5.05%
EPS Next 3Y6.47%
EPS Next 5YN/A
Revenue Next Year3.78%
Revenue Next 2Y4.6%
Revenue Next 3Y3.74%
Revenue Next 5Y1.51%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 15.06, GHC is valued correctly.
- 66.67% of the companies in the same industry are more expensive than GHC, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of GHC to the average of the S&P500 Index (27.38), we can say GHC is valued slightly cheaper.
- Based on the Price/Forward Earnings ratio of 16.77, the valuation of GHC can be described as correct.
- The rest of the industry has a similar Price/Forward Earnings ratio as GHC.
- The average S&P500 Price/Forward Earnings ratio is at 24.29. GHC is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.06 | ||
| Fwd PE | 16.77 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, GHC is valued cheaper than 83.33% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, GHC is valued a bit more expensive than the industry average as 73.33% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 150.52 | ||
| EV/EBITDA | 7.53 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GHC does not grow enough to justify the current Price/Earnings ratio.
- The decent profitability rating of GHC may justify a higher PE ratio.
PEG (NY)4.37
PEG (5Y)1.71
EPS Next 2Y5.05%
EPS Next 3Y6.47%
5. Dividend
5.1 Amount
- GHC has a Yearly Dividend Yield of 1.57%.
- GHC's Dividend Yield is comparable with the industry average which is at 1.73.
- Compared to an average S&P500 Dividend Yield of 1.84, GHC has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.57% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y5.05%
EPS Next 3Y6.47%
BIT:GHC (1/20/2026, 10:46:34 AM)
5.42
-0.08 (-1.45%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-14 2025-11-14
Earnings (Next)N/A N/A
Inst Owners11.85%
Inst Owner ChangeN/A
Ins Owners63%
Ins Owner ChangeN/A
Market Cap488.88M
Revenue(TTM)690.85M
Net Income(TTM)31.91M
Analysts84
Price Target6.73 (24.17%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.57% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.06 | ||
| Fwd PE | 16.77 | ||
| P/S | 0.71 | ||
| P/FCF | 150.52 | ||
| P/OCF | 17.5 | ||
| P/B | 1.47 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.53 |
EPS(TTM)0.36
EY6.64%
EPS(NY)0.32
Fwd EY5.96%
FCF(TTM)0.04
FCFY0.66%
OCF(TTM)0.31
OCFY5.71%
SpS7.66
BVpS3.7
TBVpS-0.44
PEG (NY)4.37
PEG (5Y)1.71
Graham Number5.47
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.66% | ||
| ROE | 9.57% | ||
| ROCE | 9.13% | ||
| ROIC | 6.52% | ||
| ROICexc | 6.77% | ||
| ROICexgc | 14.86% | ||
| OM | 9.37% | ||
| PM (TTM) | 4.62% | ||
| GM | 44.9% | ||
| FCFM | 0.47% |
ROA(3y)2.83%
ROA(5y)2.81%
ROE(3y)7.12%
ROE(5y)6.88%
ROIC(3y)4.41%
ROIC(5y)3.91%
ROICexc(3y)4.63%
ROICexc(5y)4.13%
ROICexgc(3y)10.78%
ROICexgc(5y)9.37%
ROCE(3y)6.5%
ROCE(5y)5.8%
ROICexgc growth 3Y7.97%
ROICexgc growth 5Y2.8%
ROICexc growth 3Y6.71%
ROICexc growth 5Y0.74%
OM growth 3Y-0.19%
OM growth 5Y-3.37%
PM growth 3Y-11.52%
PM growth 5Y-7.03%
GM growth 3Y0.36%
GM growth 5Y-1.06%
F-Score5
Asset Turnover0.79
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 70.49 | ||
| Debt/EBITDA | 2.47 | ||
| Cap/Depr | 94.13% | ||
| Cap/Sales | 3.57% | ||
| Interest Coverage | 6.62 | ||
| Cash Conversion | 30.7% | ||
| Profit Quality | 10.18% | ||
| Current Ratio | 1.16 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 1.97 |
F-Score5
WACC6.58%
ROIC/WACC0.99
Cap/Depr(3y)82.25%
Cap/Depr(5y)102.09%
Cap/Sales(3y)4.73%
Cap/Sales(5y)5.79%
Profit Quality(3y)118.21%
Profit Quality(5y)101.66%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.11%
EPS 3Y5.52%
EPS 5Y8.81%
EPS Q2Q%2.71%
EPS Next Y3.45%
EPS Next 2Y5.05%
EPS Next 3Y6.47%
EPS Next 5YN/A
Revenue 1Y (TTM)10.44%
Revenue growth 3Y18.48%
Revenue growth 5Y18.92%
Sales Q2Q%3.08%
Revenue Next Year3.78%
Revenue Next 2Y4.6%
Revenue Next 3Y3.74%
Revenue Next 5Y1.51%
EBIT growth 1Y-8.88%
EBIT growth 3Y18.26%
EBIT growth 5Y14.91%
EBIT Next Year68.09%
EBIT Next 3Y22.98%
EBIT Next 5Y16.09%
FCF growth 1Y-88.34%
FCF growth 3Y4.79%
FCF growth 5Y6.69%
OCF growth 1Y-35.2%
OCF growth 3Y-1.23%
OCF growth 5Y13.09%
GAROFALO HEALTH CARE SPA / GHC.MI FAQ
What is the ChartMill fundamental rating of GAROFALO HEALTH CARE SPA (GHC.MI) stock?
ChartMill assigns a fundamental rating of 4 / 10 to GHC.MI.
What is the valuation status for GHC stock?
ChartMill assigns a valuation rating of 4 / 10 to GAROFALO HEALTH CARE SPA (GHC.MI). This can be considered as Fairly Valued.
How profitable is GAROFALO HEALTH CARE SPA (GHC.MI) stock?
GAROFALO HEALTH CARE SPA (GHC.MI) has a profitability rating of 6 / 10.
What is the financial health of GAROFALO HEALTH CARE SPA (GHC.MI) stock?
The financial health rating of GAROFALO HEALTH CARE SPA (GHC.MI) is 4 / 10.
What is the expected EPS growth for GAROFALO HEALTH CARE SPA (GHC.MI) stock?
The Earnings per Share (EPS) of GAROFALO HEALTH CARE SPA (GHC.MI) is expected to grow by 3.45% in the next year.